基于针刺的治疗对慢性阻塞性肺疾病的疗效:系统评价与Meta分析
该系统评价与Meta分析检索2000年1月至2025年5月多个数据库,纳入25项随机对照试验,评估针刺治疗COPD的疗效。Meta分析仅针对稳定期COPD,结果显示针刺在6分钟步行距离、Borg量表、FEV1和FVC上显著优于对照,但SGRQ和CAT无显著差异。
要点
- 针刺可显著改善稳定期COPD患者的6分钟步行距离和Borg量表评分。
- 针刺可显著改善稳定期COPD患者的FEV1和FVC。
- 针刺对SGRQ和CAT无显著改善,证据质量以中等为主。
核心结论
- 基于针刺的治疗可显著改善COPD患者的6分钟步行距离、Borg量表、FEV1和FVC。
- 纳入研究以中等质量为主,提示仍需提高研究质量以确保数据可信度。
研究设计与样本
- 系统评价与Meta分析,检索Medline、Cochrane Library、Web of Science、Embase、CNKI、万方、维普和SinoMed,发表时间2000年1月1日至2025年5月1日。
- 共检索到1294篇文章,最终纳入25项符合标准的随机对照试验。
- 根据CONSORT评价,8项研究为高质量,16项为中等质量,1项为低质量。
主要发现
- 因结局参数异质性及AECOPD研究数量有限,Meta分析仅针对稳定期COPD进行。
- 针刺治疗在主要结局6分钟步行距离上显著优于对照(p < 0.01)。
- 针刺治疗在次要结局Borg量表(p < 0.05)、FEV1(p < 0.01)和FVC(p < 0.05)上显著优于对照。
- 圣乔治呼吸问卷(SGRQ)和COPD评估测试(CAT)未发现显著差异。
关键数值与推荐
- 纳入标准为评估任何形式针刺治疗COPD稳定期或急性加重期(AECOPD)的随机对照试验。
- 研究完整性依据CONSORT和STRICTA指南评价。
- Meta分析使用Cochrane RevMan进行。
临床怎么用
- 针刺可作为稳定期COPD的辅助治疗,改善运动耐量(6MWD)、呼吸困难(Borg量表)和肺功能(FEV1、FVC)。
- 对生活质量和症状评分(SGRQ、CAT)的改善证据不足,需结合其他干预。
局限性
- AECOPD研究数量有限,无法进行Meta分析。
- 结局参数存在异质性,仅稳定期COPD可合并分析。
- 纳入研究以中等质量为主,证据可信度有待提高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COPD population will steadily increase due to continuous exposure to COPD risk factors and the aging demographics. Acupuncture, as a common modality in complementary medicine, has been widely applied in the treatment of COPD in recent years. However, systematic reviews of the efficacy of acupuncture-based traditional Chinese external treatment in COPD are relatively scarce and when considering the quality of randomized controlled trials evidence remains insufficient. OBJECTIVE: To provide an updated systematic review and meta-analysis of the effectiveness of acupuncture-based treatment for COPD using the latest data and a rigorous evaluation system. METHODS: Randomized controlled trials evaluating any form of acupuncture in COPD in a stable phase or acute exacerbation phase (AECOPD) were selected from Medline, Cochrane Library, Web of Science, Embase, CNKI, the Wanfang database, VIP, and SinoMed, encompassing a publication period from January 1st, 2000, to May 1st, 2025. The completeness of each study was evaluated according to the Consolidated Standards of Reporting Trials (CONSORT) and Standards for Reporting Interventions in Clinical Trials of Acupuncture guidelines (STRICTA). A meta-analysis was conducted using Cochrane RevMan. RESULTS: A total of 1294 articles were retrieved from the selected database and 25 articles meeting the criteria were included. According to CONSORT, 8 studies rated as high quality, 16 studies as moderate quality, and 1 study as low quality. Due to the heterogeneity of outcome parameters and the limited number of AECOPD studies, meta-analysis could only be performed for COPD in the stable phase. In the meta-analysis, acupuncture-based treatments were significantly superior to controls in COPD in the primary outcome 6-minute walk distance (6MWD: p < 0.01) and the secondary outcomes Borg Scale (p < 0.05), forced expiratory volume in 1 s (FEV1: p < 0.01) and forced vital capacity (FVC: p < 0.05); no significant differences were found in the St. George's Respiratory Questionnaire (SGRQ) and the COPD Assessment Test (CAT). CONCLUSIONS: Acupuncture-based treatments significantly enhance the 6MWD, Borg Scale, FEV1 and FVC in COPD patients. The predominance of moderate quality studies indicates the ongoing need for improvement to ensure the credibility of data.
引用
- Li M, Zheng S, Lederer AK, et al. Efficacy of acupuncture-based treatment in Chronic Obstructive Pulmonary Disease - A systematic review and meta-analysis. Complement Ther Med. 2025. PMID: 40712803. doi:10.1016/j.ctim.2025.103211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。